Post-Market Study to Assess iTind Safety in Comparison to UroLift
NCT: NCT04757116 · RECRUITING
NCT IDNCT04757116
StatusRECRUITING
Start Date2022-09-26
Completion2031-12-31
Brief Summary
The study objective is to evaluate the safety of the iTind device comparied to UroLift.
Frequently Asked Questions
What is Post-Market Study to Assess iTind Safety in Comparison to UroLift?
Post-Market Study to Assess iTind Safety in Comparison to UroLift is a clinical trial registered under NCT04757116. Current status: RECRUITING.
What is the status of NCT04757116?
The current status of NCT04757116 (Post-Market Study to Assess iTind Safety in Comparison to UroLift) is: RECRUITING.
When did Post-Market Study to Assess iTind Safety in Comparison to UroLift start?
Post-Market Study to Assess iTind Safety in Comparison to UroLift started on 2022-09-26.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.